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Abstract
Background: Understanding and manipulating gene function in physiological conditions is a major
objective for both fundamental and applied research. In contrast to other experimental settings,
which use either purely genetic or gene delivery (viral or non-viral) strategies, we report here a
strategy based on direct protein delivery to central nervous system (CNS) tissues. We fused Cre
recombinase with cell-penetrating peptides and analyzed the intracellular biological activity of the
resulting chimerical proteins when delivered into cells endowed with Cre-mediated reporter gene
expression.
Results: We show that active Cre enzymatic conjugates are readily internalized and exert their
enzymatic activity in the nucleus of adherent cultured cells. We then evaluated this strategy in
organotypic cultures of neural tissue explants derived from reporter mice carrying reporter
"floxed" alleles. The efficacy of two protocols was compared on explants, either by direct addition
of an overlying drop of protein conjugate or by implantation of conjugate-coated beads. In both
cases, delivery of Cre recombinase resulted in genomic recombination that, with the bead
protocol, was restricted to discrete areas of embryonic and adult neural tissues. Furthermore,
delivery to adult brain tissue resulted in the transduction of mature postmitotic populations of
neurons.
Conclusion: We provide tools for the spatially restricted genetic modification of cells in explant
culture. This strategy allows to study lineage, migration, differentiation and death of neural cells. As
a proof-of-concept applied to CNS tissue, direct delivery of Cre recombinase enabled the selective
elimination of an interneuron subpopulation of the spinal cord, thereby providing a model to study
early events of neurodegenerative processes. Thus our work opens new perspectives for both
fundamental and applied cell targeting protocols using proteic cargoes which need to retain full
bioactivity upon internalisation, as illustrated here with the oligomeric Cre recombinase.
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From focal demyelination or axonal degeneration events
characterizing peripheral neuropathies, to localized
genetic alterations involved in primary neuro-oncogenic
processes, understanding cell- and domain-specific gene
function in the CNS [1-4] often requires the modification
of gene expression in restricted cell populations. Cre-
mediated recombination has become a key strategy for the
spatial and temporal control of gene inactivation or over-
expression. This has been mainly achieved through
genetic approaches, by crossing transgenic mouse strains
carrying loxP-flanked ("floxed") genes with transgenic
mice expressing the Cre recombinase under the control of
specific promoters, or through viral or non-viral delivery
of Cre encoding DNA. With the latter strategy, spatial
restriction of the infected tissue to defined areas remains
challenging. As an alternative strategy, direct delivery of
therapeutic agents into cells ('transduction'), has had
numerous and encouraging attempts [5-10]. Endogenous
peptides endowed with internalisation properties (Cell
Penetrating-Peptides, hereafter termed "CPPs") have
strongly improved the efficiency of delivery [11]. Frag-
ments of TAT [10,12], FGF [13], and homeoproteins are
efficient peptidic vectors, which do not have obvious del-
eterious impact on cell survival; they have been com-
bined, either chemically or genetically, with different
macromolecular cargoes [5-9]. However, the restricted
delivery of such compounds in topographically focalized
territories has not been directly evaluated in the case of
neural cells, which are highly heterogeneous in term of
spatial identity. We have addressed this issue with the
intra-cellular delivery of Cre recombinase fused to CPPs, a
strategy which has been already well described [13-18].
Cre recombinase is a large hydrophilic enzyme frequently
used to perform targeted genomic recombination [19],
resulting in permanent reporter transgene expression
when using dedicated genetic backgrounds. This func-
tional read-out unambiguously ensures the presence of a
biologically active Cre protein inside the nucleus, con-
trasting with the visualisation of protein internalization
that has lead to conflicting results [20-25]. We show the
efficient delivery of the active enzyme in topologically
restricted cell populations and provide several examples
of the applications of this technology to neuronal target-
ing and cancer research, a strategy which obviates the need
for sustained expression of Cre recombinase [26-29]
through genetic procedures.
Results
Fusion to Penetratin-based CPPs preserves recombinase 
activity and promotes nuclear Cre internalization
Cre recombinase coding sequence was genetically inserted
in frame with several peptidic coding sequences coding
for CPPs and the recombinant proteins were purified from
bacteria (Fig. 1A & Additional file 1A). Enzymatic activity
was monitored in cell-free conditions, through recombi-
nation of a target linear plasmid harbouring two loxP sites.
All fusion proteins displayed similar specific recombina-
tion activities, in the range of 4 units/μg – except for Tat-
Cre, which was significantly more active (16 units/μg),
outperforming a commercial Cre (NEB #MO298, 11
units/μg; see Additional file 1B). As both the nuclear local-
ization signal (NLS) and the highly basic character of the
Tat and Penetratin sequences might have enhanced Cre
biological activity by increasing its nuclear accumulation,
independently of the internalization process [30,31], the
recombination activities of histidine-tagged Cre conju-
gates (HC, hNC and H3C) were further evaluated by tran-
sient transfection. The three coding sequences, sub-cloned
into a mammalian expression plasmid, were expressed in
CV1B cells, which display β-Galactosidase reporter activ-
ity upon Cre-mediated recombination [32]. Cre immuno-
detection indicated that all proteins displayed similar
expression and nuclear accumulation levels (see Addi-
tional file 2A–C). Furthermore, detection of reporter activ-
ity showed similar target recombination efficiency for all
tested Cre conjugates, consistent with previous observa-
tions [30,31]. This efficacy further applied to the Antp
secretion signal-appended Penetratin conjugates (H23C
and H23NC), suggesting a robust nuclear targeting by the
Penetratin moiety [33]. These results rule out nuclear
addressing as a limiting step in Cre nuclear activity during
protein transduction assays – which thus allows correlat-
ing their transduction efficiencies with the internalization
step.
We then evaluated the biological activity of these proteins
upon transduction of the adherent CV1B reporter cell line
[32]. Fusion of HC to Tat, NLS or Penetratin, resulted in
equivalent recombination efficiency and cell survival (Fig.
1B–D) upon exposure for 60 mn. Maximal activity was
obtained at 4 μM, resulting in 80% of β-Galactosidase
positive cells (Fig. 1D). By contrast, the native HC protein
displayed a low but significant transduction rate, with less
than 20% of reporter-expressing cells. Interestingly, as
previously reported, the transduction efficiency of NLS,
which is not considered as a bona fide CPP, was twice that
of Cre alone [32]. The simultaneous addition of both NLS
and Penetratin sequences to Cre protein (H3NC) only
slightly enhanced the transduction efficiency compared to
H3C (see Additional file 2D). Reducing the exposure of
cells to H3NC (4 μM) from 60 down to 15 mn resulted in
recombination efficiency levels close to maximum (see
Additional file 2E), suggesting a fast interaction of the pro-
tein with the cell surface.
CPP-Cre fusion proteins as a new tool for the study of 
neural development
We next addressed whether CPP-Cre mediated recombi-
nation would be suitable for the study of neural tissue. In
preliminary experiments we had observed that primary
neuronal cell cultures were readily amenable to transduc-Page 2 of 11
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efficiency of transduction at the tissular level, we devel-
oped transduction assays on explants [34-36] of adult or
embryonic CNS regions derived from Cre-inducible
reporter transgenic mice. The explants were cultured in
serum-free medium and subsequently exposed to CPP-
Cre fusion proteins (see Additional file 3). Tissue frag-
ments were overlaid with a 1 μl drop of protein solution
(10 to 400 ng/μl) and assayed for reporter activity, 1 up to
10 days later. None of the explants from reporter strains
used in this study displayed recombination events upon
exposure to vehicle solution (see Additional file 4).
Firstly, drops of CPP-Cre were applied at the centre of tel-
encephalic explants from E12.5–E16.5 mouse embryos
(Fig. 2 and Additional file 5). Dose-response assays
showed that exposure to most of these conjugates resulted
in a steep response, with no or barely detectable recombi-
nation events below 100 ng/μl, and maximal reporter
expression from 200 ng/μl with all tested transgenic
reporter strains (see Additional files 5 and 6). Since all
Genomic recombination upon transduction of CPP-Cre conjugates in reporter cellsFigure 1
Genomic recombination upon transduction of CPP-Cre conjugates in reporter cells. (A) Peptidic additions to Cre 
recombinase: 'NLS', nuclear localization signal; '3' or 'Penetratin', Antennapedia transduction domain, see [5]; '23' or 'SEC', 
Antennapedia secretion signal, see [33]; 'TAT', transduction domain from HIV Tat protein (see [10]); 'myc', myc tag; 'his', poly-
histidine tag. See also Additional file 1. (B) β-Galactosidase activity (arrow) of CV-1B reporter cells following 1 h incubation 
with H3C. Arrows, pairs of daughter cells from individually transduced cells. (C) Bradford quantification of total protein con-
tent after conjugate exposure showed unaffected cellular survival upon transduction. MTT cell viability assays on the same sam-
ples indicated that conjugate doses only above 5 μM were cytotoxic (not shown). (D) Dose-dependent transduction assay. 
Reporter activity was quantified 48 h after 1 h exposure to conjugates. The indicated proteins showed strongest activity at 4 
μM, with a maximum for H3C. H3NC reached similar levels (see Additional file 2D). Scale bar in B represents 1800 μm.Page 3 of 11
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with similar efficiencies, only tissues exposed to H3NC
were hereafter used to illustrate representative assays in
Fig. 2, 3 and 4. As documented in Fig. 2A, B, reporter-
expressing cells from R26R-derived explants were detected
throughout the explant from the 200 ng/μl concentration
on (see also Additional file 6). In contrast, conjugate titres
below this limit resulted in restricted clusters of targeted
cells (see Additional file 6). Within live cortical explants
from transgenic mice carrying fluorescent inducible
reporters, gene expression was detected as soon as eight
hours after transduction by direct fluorescence (Fig. 2C).
Indirect immunodetection and confocal analysis (Fig.
2D–G) performed 72 h later suggested that neurons might
be preferential targets for CPP-Cre internalization, based
on the morphology of the expressing cells (Fig. 2D, E) –
consistent with previous observations [37].
Although indicative of efficient recombination, the drop
delivery approach resulted in a heterogeneous distribu-
tion of reporter-expressing cells, either at the centre or at
the periphery of the explant, which could reflect the per-
sistent drift of the proteins towards the edge of the
explants. We thus examined whether recombination
could be further restricted to cell subpopulations of the
developing CNS thanks to the use of lineage-specific pro-
moters. For this purpose we targeted a single lineage of
neuroblasts in a model of neuronal apoptosis. The fusion
proteins were used to transduce E9.5–E14.5 spinal cord
explants from the Dbx1-Dta strain (kindly provided by Dr
A. Pierani [38,39]), in which only Dbx1-positive interneu-
rons express the pro-apoptotic diphtheria toxin A frag-
ment. Apoptosis can then be evidenced by induction of
activated caspase III. Upon transduction, apoptotic cells
could be detected only within transgenic explants exposed
to Cre fusion proteins (Fig. 3B) but not with vehicle solu-
tion (see Additional file 4). These cells were arranged
along two parasagittal lines, consistent with the distribu-
tion of Dbx1 positive interneurons (A. Pierani, personal
communication). In contrast, fusion proteins did not
induce significant apoptosis in non-transgenic explant
(Fig. 3A). Expression of the target transgene, performed
here to monitor early events during cell death, can thus be
induced in a lineage-restricted population, depending
upon the activity of its promoter. Furthermore, these
observations underline the innocuous character of the
exposure to CPP-Cre conjugates, as illustrated by the
absence of significant apoptosis in Dbx1 negative cells.
Next we asked whether topologically restricted recombi-
nation could be obtained using ubiquitously expressed
instead of cell-type restricted reporter transgenes. To spa-
tially restrict recombination, we focused the territory of
protein delivery using neutral beads soaked with CPP-Cre
proteins. The beads were implanted onto embryonic brain
explants derived from the Z/AP strain, in which alkaline
phosphatase is expressed upon Cre-mediated recombina-
tion. As illustrated in Fig. 3C, cohorts of cells were
detected only in close proximity of the beads (inset). In
contrast, in a parallel drop assay using the same protein
solution used for bead soaking, positive cells were widely
dispersed throughout the explant surface (Fig. 3D). The
limited diffusion of the fusion proteins using focal bead
CNS explants from Cre-dependent transgenic embryos dis-played reporte  activity upon exposure to CPP-Cre fu ion roteinsFigure 2
CNS explants from Cre-dependent transgenic 
embryos displayed reporter activity upon exposure 
to CPP-Cre fusion proteins. Telencephalic explants of 
dissected fragments from the embryonic brain (see Addi-
tional file 3), were obtained and cultured as previously 
described, then exposed to protein conjugates added at the 
center of the explant (asterisk). Two to ten days later, trans-
gene-expressing cells (arrows) were detected by reporter 
enzymatic activity (A, B), intrinsic fluorescence (C), or immu-
nohistochemistry (D-E). Vehicle-treated explants were 
devoid of reporter expressing cells (see Additional file 4). (A, 
B) Explants (R26R strain) exposed for 96 h to a 1 μl drop of 
100 ng/μl H3NC. Visualization of reporter activity (X-gal 
staining; positive blue cells indicated by arrows) showed 
reporter-expressing cells, located mainly in the peripheral 
domain (B). (C) Explant from RYFP strain, exposed for 8 h to 
a 1 μl drop of 100 ng/μl H3NC. Live fluorescence recording 
(GFP channel; bright green cells, arrow) shows early recom-
binant cells in the centre of the explant. (D-E), YFP immun-
ofluorescence analysis using a pan-GFP antibody revealed 
reporter expression in large cell clusters, 72 h after H3NC 
transduction (1 μl drop of 100 ng/μl). In (D), labelled cells 
were classically documented while in (E), reporter YFP was 
analysed using confocal analysis (pseudo-colors GLOW-LUT 
converted representing signal intensity, blue indicating satu-
rated signal). In A-E, arrows point to representative recom-
binant cells, including those with a morphology suggestive of 
neuronal identity in pictures D-E. For the whole figure, the 
scale bar in A represents: A, 350 μm; B, 750 μm; C, 150 μm; 
D, 50 μm; E, 1000 μm.Page 4 of 11
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clusters.
In order to verify that neuronal populations were actually
transduced using this protocol, explants from the axon-
specific TGZ transgenic strain were incubated with CPP-
Cre soaked beads. Following incubation, numerous
reporter-expressing neuronal cells characterized by β-
Galactosidase positive nuclei and MARCKS-eGFP positive
neurites were detected at the vicinity of the beads (Fig. 3E,
F). This assay further illustrates the modularity of the sys-
tem, with the restriction of reporter expressing cells by a
combination of focal delivery and promoter-specific
transgenic lines.
Whether cells from adult tissues would be similarly ame-
nable to CPP-mediated transduction of Cre recombinase
remained to be determined. Serial sections from adult
brains of the same mouse strains were exposed to drops of
CPP-Cre conjugates. A robust staining developed, deline-
ating the laminar organization of the brain as illustrated
in Fig. 4. Noticeably, all Penetratin-based conjugates dis-
played similar targeting efficiency with the R26R strain,
such that transgene-expressing cells spanned the whole
surface and thickness of all exposed explants (see Addi-
tional File 5). A higher concentration of recombinant cells
could be detected in cell-dense domains such as progeni-
tor-rich periventricular layers (Fig. 4A, B) and striatal clus-
ters (Fig. 4A, C). Remarkably, when cerebellar slices were
exposed to the drop transduction assay, the predominant
reporter-expressing population was constituted by
Purkinje cells (Fig. 3D; see [14]). Transduction thus also
occurred in mature neurons of the adult CNS.
Discussion
We recently reviewed [11] the encouraging properties of
CPP-based conjugates, including their neural tropism.
Efficient direct protein delivery into neural nuclei would
greatly improve fundamental and clinical research in neu-
roscience. Here, we developed non-viral transduction
assays based on organotypic cultures from transgenic mice
as a surrogate model of live CNS tissue. As reported by
others, including in vivo studies [8,18,31], we confirm that
fusion proteins between CPPs and a large enzyme, the Cre
recombinase, are readily translocated through cell mem-
branes and further shuttled inside the nucleus to target
genomic loci. Since successful delivery in the CNS of other
kind of proteins fused to CPPs have been reported in vivo
[8,11,40,41], our strategy might thus be not limited to Cre
conjugates.
Our study further expands the applications of this strategy
to neural explant culture. High levels of recombination
were reached on explants upon exposure with as few as
200 ng of protein, and transduction resulted in a mosaic
of recombined and unaffected cells within live tissues.
Although easy to perform and efficient, the drop approach
is poorly reproducible in terms of spatial distribution,
mainly because the diffusion of the protein depends on
the shape of the explant. With the bead protocol, spatial
restriction of recombination to defined areas can easily be
achieved, depending upon the position of the bead. In the
explant assays, most of the Cre conjugates displayed sim-
ilar biological activity (see Additional file 5). We only
noticed enhanced specific activity of Tat-Cre for cell-free
DNA recombination, compared to that of Penetratin-
based conjugates (4-fold) – although their cellular activi-
ties were similar. This might reveal differential properties
of these two CPPs, at least in the context of fusion with
Cre protein.
Direct delivery of Cre conjugates presents several advan-
tages over viral strategies, although these latter have been
successfully used. In addition to the technical and safety
limitations inherent to the production of viruses [42,43],
viral-mediated Cre delivery results in the prolonged
expression of the enzyme, with possible adverse effects
[16,27]. With our approach, we did not observe a dra-
matic increase in the number of recombinant cells
between 8 h and 96 h following treatment (compare Fig
3C, and 3D–E), suggesting the temporal restriction of the
recombination events to the first hours of incubation.
Indeed, a similar situation is observed in cell culture,
where optimal recombination activity is almost reached
after a 15 mn exposure to Cre conjugates (see Additional
file 2E). Among credible possibilities, the limited stability
of the protein in the extracellular medium might account
for this observation. This strategy might be used in a pulse
application for selecting Cre-dependent genomic con-
structs or removing undesirable entities from manipu-
lated stem cells, as performed in [16,18].
On cerebral explants, neurons were prime targets for
transduction, both upon generalized (drop) and focalized
(bead) delivery. In terms of ontogenesis, we and others
previously showed that regionalized properties develop
early during mouse CNS formation [44-46], resulting
from the combined activities of recently identified genetic
programs. Which mechanisms underlie neurogenesis
might be best understood through focal manipulation of
gene function in defined territories. Interestingly, the
function of both proliferating and mature post-mitotic
neurons of the adult brain can also be approached with
this strategy, although the efficiency of the transduction
seems decreased.
In adult cerebellar explants, the preferential restriction of
recombination events to Purkinje neurons was unex-
pected and might rely on their larger membrane area
offered by their extensive dendritic arborization tree.
Whichever mechanism is involved, targeting of this cell
type – the largest cell and sole axonal output to extra-cer-Page 5 of 11
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normal and pathologic events during the formation and
function of the cerebellum. Peptide-mediated non-viral
transfer of proteic cargoes could thus offer a valuable alter-
native strategy to viral-mediated gene transfer using
Purkinje cell-specific targeting elements [29], with the
advantage of a non-toxic and rapidly cleared vector [27].
Conclusion
Controlled inactivation or over-expression of genes both
at the spatial and temporal level has become a key strategy
in the study of gene function. Our study provides an alter-
native and complementary strategy to the use of Cre
expressing mouse strains or of viral-mediated delivery that
can be applied to both explant culture and in vivo models.
The originality of this strategy relies on the spatial and
temporal restriction of recombinant cells without the
need of specific promoters. We demonstrate that this
method of transduction could find innovative applica-
tions in different areas of neuroscience including neural
development and neurophysiology.
Methods
Expression vectors of CPP-Cre fusion proteins
Plasmids were derived from pTHCremyc and pTHnlsCre-
myc constructs harboring a T7 polymerase promoter. CPP
sequences were inserted in frame by oligonucleotide
insertion in the unique restriction sites SpeÉ and KpnÉ
localized between polyhistidine and Cre recombinase
coding sequences (see Additional file 1). Eukaryotic
expression plasmids used in this work were designed by
subcloning of the sequences encoding for CPPs-Cre-myc
(without His tag) derived from pTH vectors into pTL plas-
mids (pSG5 derivative), in which the expression is under
control of a viral SV40 promoter. All plasmid sequences
were verified by sequencing. HisCreTAT expression plas-
mid [10] was kindly provided by Dr S.F. Dowdy (UCSD,
La Jolla, CA, USA).
Expression and purification of recombinant fusion proteins
pTH plasmids encoding different CPPs-Cre fusion pro-
teins were used to transform the E. coli strain
BL21(DE3)pLysS (Novagen), allowing isopropyl β-D-thi-
ogalactoside (IPTG)-inducible expression of His-tagged
proteins. An enriched medium of Luria Broth/2%glucose
containing 50 μg/ml ampicillin and 34 μg/ml chloram-
phenicol was used for overnight preculture. 500 ml cul-
tures of LB at 50 μg/ml ampicillin and 0.5% glucose were
then inoculated by 1:20 dilution of preculture and grown
at 37°C until OD(600 nm) reached 0.4. Protein overexpres-
sion was induced by 1 mM IPTG for 3 hours at 28°C. Cells
were harvested by centrifugation and pellets were frozen
dry at -80°C for storage. Cell pellets were resuspended in
lysis buffer (500 mM NaCl, 25 mM Hepes, 5 mM imida-
zole, 5 mM MgCl2, 50 μg/ml DNAse, 2 μg/ml RNAse, and
proteases inhibitors; Invitrogen) in a final volume of 10
ml. Cleared lysates were obtained by French press bacte-
rial disruption and subsequent centrifugation for 1 hour
at 12000 g at 4°C. After 0.45 μm filtration, the superna-
tant was loaded onto Histrap Ni2+ affinity column (Amer-
sham) and subsequently washed with 10 bed volumes of
a 500 mM NaCl, 25 mM Hepes, 10 mM imidazole solu-
tion. Recombinant proteins were purified through one-
step FPLC chromatography, by linear gradient-mediated
elution from 10 to 500 mM imidazole. Fractions were
Focal recombination obtained through genetic and mechani-cal pproachesigure 3
Focal recombination obtained through genetic and 
mechanical approaches. (A, B) Genetic approach. Condi-
tional induction of a caspase-dependent pro-apoptotic pro-
gram in a neuronal subpopulation. Flat-mount embryonic 
spinal cord explants, from wild-type (A) or Dbx1-DTA strain 
(B), exposed for 96 h to 1 μl of 400 ng/μl H3NC. Activated-
caspase III immunodetection showed induction of early steps 
of apoptosis only in transgenic explants exposed to the con-
jugate (B; arrows: representative positive cells, purple stain-
ing). The apoptotic marker was not induced in non-
transgenic tissue (A). Likewise, vehicle solution did not 
induce significant apoptosis (see Additional file 4C). Red dou-
ble arrow: floorplate (see also Additional file 3). (C-F) 
Mechanical approach. Focal conjugate delivery produced 
clusters of recombined cells. (C) H3NC-soaked beads (200 
ng/μl) were deposited onto Z/AP cortical explants. hPLAP 
reporter activity was monitored 24 h later (purple precipi-
tate). Inset, clusters of radiating positive cells. (D) In contrast, 
the drop assay using the same protein solution (200 ng/μl) on 
parallel explants led to widely dispersed reporter-expressing 
cells (inset, higher magnification). (E-F) Combination of 
genetic and focalized restriction of cell targeting. Detection 
of simultaneous reporters (β-Galactosidase, blue; GFP, 
brown; arrow) induced by H3NC (200 ng/μl) in TGZ cortical 
explants. In both C (top cluster of positive cells, asterisk) and 
F explants (center, asterisk), one bead was removed, expos-
ing cells in contact with the beads. Arrows (E, F): representa-
tive nuclei surrounded by dense axon bundles, suggestive of 
neurons. For the whole figure, scale bar in A represents: A, 
B, E, 300 μm; C, D, 1000 μm; F, 150 μm.Page 6 of 11
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ence of purified protein were pooled (1 to 4 mg) and dia-
lyzed overnight at 4°C in Pierce 10 K dialysis cassettes
against pH 5 dialysis buffer (20 mM Sodium Acetate pH
5, 10 mM β-mercapto-ethanol, 40 mM NaCl). After dialy-
sis and removal of precipitated material, protein concen-
tration was determined using Bradford assay and 12%
SDS-PAGE analysis and ranges from 0.4 to 1 μg/μl (com-
pared to 1 to 2 μg/μl before dialysis). Proteins were stored
at -80°C. Glycerol cryoprotection was omitted in order to
avoid possible interference with membrane permeability
upon protein exposure to live cells.
Cell-free assay of CPP-Cre recombinase activity
Recombination assays were performed in 10 μl of buffer
(50 mM Tris-HCl pH 7.5; 33 mM NaCl; 10 mM MgCl2)
containing 250 ng of XmnÉ-linearized pLox2 plasmid
(Clonetech, [47]). To compare the efficiency of recombi-
nation in vitro, a range of 100, 50, 25, 12.5 and 6.25 ng of
purified Cre fusion proteins, were added, for 1/10th of the
reaction volume. After 30 mn incubation at 37°C, reac-
tions were stopped by adding 2 μl of 6× loading buffer
(0.025% Bromophenol blue; 0.025% xylene cyanol; 60%
glycerol; 1% SDS; 100 mM EDTA) and inactivation for 10
mn at 70°C. The reactions were then resolved on a 1.5%
agarose gel. Quantification of the recombination activity
was based on the comparison with a commercial Cre
enzyme (NEB) and expressed according to the manufac-
turer unit definition.
Protein transduction: Cellular-based assays of CPP-Cre 
activity
Adherent CV1B fibroblasts were kindly provided by Dr F.
Tronche and used as described in the original publication
[32]. In this reporter cell line, a floxed neomycin resist-
ance/poly-adenylation cassette has to be excised to allow
E. coli lacZ expression. Cre recombinase activity in the
nucleus thus results in β-Galactosidase activity. The cells
were cultured in Dulbecco's Modified Eagles medium
(DMEM)/F12 medium (Gibco) supplemented with 10%
fetal calf serum (FCS), penicilline (50 U/ml), streptamy-
cine (50 μg/ml), G418 (100 μg/ml) and DnaseI (10 μg/
ml). For internalization experiments, 5000 cells/well were
seeded into 96-well plates coated with 1.5 μg/ml poly-
ornithine (Sigma), then washed in DMEM/F12 serum-free
medium. Upon internalization, cells were incubated in
presence of CPP-Cre proteins diluted in DMEM/F12 sup-
plemented with 10 mM HEPES and 100 μg/ml bovine
serum albumine (BSA). Protein solutions were prepared
extra-temporaneously. After protein exposure (15 to 60
mn), cells were washed with 10% FCS medium, then re-
incubated for 24 or 48 hours, and subsequently moni-
tored for reporter β-Galactosidase activity using either
CPRG assay (see below) or Xgal staining (as previously
described [34,35]).
Plasmid DNA transfection experiments
CV1 fibroblasts were grown for 24 h in 10%FCS. Lipofec-
tion of 50000 cells was carried out by adding into each 24-
well a mixture of Lipofectamine (Invitrogen), 200 ng of
control Alkaline Phosphatase (AP)-encoding plasmid and
200 ng of CPP-Cre encoding plasmid – all diluted in Opti-
mem medium. After 6 h of incubation, transfection
medium was substituted by 10% FCS and incubation was
resumed for 24 h. Cells were washed with PBS, fixed in
2.5% glutaraldehyde for 5 mn on ice and assayed for β-
Galactosidase activity by Xgal staining. AP was detected
using NBT and BCiP for 30 mn at room temperature.
Enzymatic assays
To detect β-Galactosidase activity by CPRG assay, cells
were washed twice with PBS, lysed in 50 μl buffer (0.1%
Triton X-100, 250 mM Tris-HCl pH 8.0) frozen-thawed
twice at -80°C from 37°C. 10 μl aliquots were reserved for
quantitation with Bradford assay. The lysates were mixed
with 150 μl of CPRG detection solution (2.5 ml CPRG
substrate stock at 4 mg/ml, 35 μl β-Mercapto-ethanol 14.3
M, 7.5 ml Buffer pH 7.0 (60 mM Na2HPO4, 40 mM
NaH2PO4, 10 mM KCl, 1 mM MgSO4). After incubation
for 15, 30, 60, 90, and 120 mn, OD(570 nm) was assessed
using an ELISA plate reader. CPRG data obtained from the
wells treated with CPPs-Cre proteins were normalized
against background signals obtained with vehicle-treated
cells. Bradford assay was performed according to the man-
ufacturer's instructions (Biorad). In parallel, an aliquote
of each sample was used to monitor cell viability using the
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide) cell death assay (Millipore procedure).
CPRG/MTT ratios were used to quantify β-Galactosidase
activity.
Immunohistochemistry
All immunodetections were performed as previously
described [34-36], using the following primary antibodies
at 1/500: anti-β-Galactosidase (Cappel), anti-GFP (which
recognizes all GFP-derived isoforms, including YFP;
Molecular Probes), and secondary antibodies from Jack-
son labs at 1/200 (against rabbit and mouse IgGs) conju-
gated to either horseradish peroxidase or fluorescein.
Anti-Cre antibody raised against a Cre fusion protein was
a gift from Dr A. Prochiantz
Cre-dependent reporter transgenic mouse strains
For most reporters in this work, the internalization of the
Cre was monitored by genomic excision of a "floxed" cas-
sette, allowing the expression of various indicator genes.
The transgenic constructs contained stop or βgeo (β-
Galactosidase/neomycine resistance) cassettes, flanked by
two loxP sites in direct orientation. The cassette sequence
is removed by excisive Cre-mediated recombination,
allowing the expression of the reporter gene. Mice werePage 7 of 11
(page number not for citation purposes)
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and handled according to institutional recommendations.
Excision of the underlined sequence led to the expression
of the reporter moiety indicated in bold:
R26R [48]: pROSA trapped promoter – loxP – STOP –
loxP – β-geo (nuclear β-Galactosidase);
RYFP [49]: pROSA trapped promoter – loxP – STOP – loxP
– YFP (cytoplasmic+nuclear Yellow Fluorescent Pro-
tein);
Z/AP [50]: pCMV-pβ-actin – loxP – βgeo – loxP – hPLAP
(membrane human Placental Alkaline Phosphatase);
TGZ [51,52]: pCMV – loxP – STOP – loxP –
MARCKS::eGFP-IRES-nlsLacZ (axonal Green Fluores-
cent Protein and nuclear β-Galactosidase);
Dbx1-DTA [38]: pDbx1 – loxP – STOP – loxP – DTa
(Diphteric Toxin A-fragment).
Absence of leaky transgene expression and presence of
proper specific reporter expression was genetically con-
trolled using mating with Cre-driver strains (not shown).
Ubiquitous reporter expression is displayed upon recom-
bination of the R26R, RYFP and Z/AP transgenes. In con-
trast TGZ expression is restricted to neuronal cells, and
Dbx1-Dta is specific of Dbx1+ interneurons.
Explant transduction procedure
Mice were handled according to institutional guidelines.
Embryos were obtained from mating between syngenic
mice, with detection of the vaginal plug considered as
embryonic day 0.5 ('E0.5'). Pregnant mice were subjected
to Nembutal overdose, and embryos transferred in PBS
for dissection. Vitelline yolk sac fragments were used for
genotyping according to original description of transgenic
strains. As illustrated (see Additional file 3), fragments
from several regions of the CNS including telencephalon,
cerebellum and spinal cord were dissected from trans-
genic embryos or adults. Meninges were removed and
CNS tissues were cultured on a polyester porous mem-
brane (0.22 μm, Millipore), floating above serum-free
medium (DMEM-F12 supplemented with Gibco N2 and
B27 additives), as previously described [34-36,53]. They
were challenged to express Cre-dependant transgenes
upon exposure to the same sets of CPP-Cre fusion pro-
teins, in individual wells. Vehicle solution and each con-
jugate were applied to at least two explants per series.
Necrotic explants were discarded. Exposure was per-
formed only 24 h after dissection to avoid non-specific
internalization through membranes wounds due to dis-
section. Two modalities of exposure were used. In drop
assay, a single 1 μl drop of purified protein in dialysis
buffer was slowly laid onto the exposed surface of the
explant, in the centre of the explant (see Additional file 3).
In bead assay, neutral Affi-Gel beads (150–300 μm mesh,
Biorad) were incubated with protein batches diluted to
400 ng/μl in PBS and rinsed, then deposited onto various
spots of the explant surface. In contrast with cell culture,
proteins or beads were not washed-out from the explants
and transgene expression was monitored 1 to 14 days after
treatment using dedicated procedures for the detection of
β-Galactosidase protein or activity, human Placental Alka-
line Phosphatase activity or fluorescent proteins.
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Adult tissues are amenable to topographically restricted cell targetingFigure 4
Adult tissues are amenable to topographically 
restricted cell targeting. (A-C) Adult forebrain slice 
explants (R26R strain), exposed to a 1 μl drop of 100 ng/μl 
H3NC, displayed reporter β-Galactosidase activity (blue 
staining, arrows) throughout brain regions. Boxed area in A 
is observed at higher magnification in B. Dashed lines in B 
encompass periventricular layers. (C), higher magnification in 
the striatum. The arrow points to representative recom-
binant cells arranged as glomerula. (D) Fragment of adult cer-
ebellum explants (TGZ strain) exposed to H3NC (100 ng/
μl), displayed reporter alkaline phosphatase immunopositive 
cells, most of which appear arranged in a laminar organiza-
tion suggestive of Purkinje cell layer. The arrowheads point 
to representative recombinant cells within the Purkinje cell 
layer, while the arrows indicate rare positive cells outside of 
it. For the whole figure, the scale bar in A represents: A, 
1600 μm; B, 800 μm; C, 130 μm; D, 3000 μm.Page 8 of 11
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Additional material
Additional file 1
Fusion to CPPs preserved Cre recombinase activity in both cell-free 
and cellular context. (A) Structure and SDS-PAGE electrophoretic pro-
file using Sypro staining of the bacterially-produced fusion proteins, collec-
tively designated as 'CPP-Cre' in this report. Peptidic additions did not 
significantly affect the apparent Mr of the Cre recombinase. The indicated 
conjugates averaged 45 kDa. (B) Comparison of the activity of three Cre 
fusion proteins by cell-free in vitro recombination. The Cre-mediated 
excision of a loxP-flanked target sequence reduced the size of the linear 
target plasmid pLox2, which released a shorter linear fragment and a cir-
cular fragment (annotated on the side of the gel). Linear pLox2 (pLox2*) 
was incubated for 30 mn with increasing amounts of indicated CPP-Cre 
proteins. Electrophoretic profiles showed equivalent recombination activi-
ties among HCT, H3C and HC, which were slightly lower than that of 
HNC. Underlined concentrations indicate the lowest titer with significant 
recombination. Note that while the unvectorized Cre displayed detectable 
and maximal activity at 50 ng/μl, the CPP-Cre displayed significant 
activity at 100 ng/μl.




Cre reporter activity in CV1 cells upon plasmidic transfection and pro-
teic transduction by CPP-Cre constructs. Expression of the constructs 
encoding the fusion proteins resulted in nuclear accumulation of the Cre 
conjugates (A), and nuclear β-Galactosidase reporter expression (B) in 
CV1B reporter cells. Eukaryotic versions of the plasmidic DNAs were used 
to transfect CV1B cells using lipofectamine, extensive wash and 24 h rein-
cubation before carrier and reporter analysis. Alongside, a transfection 
indicator human Placental Alkaline Phosphatase (hPLAP) encoding plas-
mid was co-transfected. In A, Cre (bright green staining) was immunolo-
calized in the nucleus of transfected cells (light blue staining). In B, β-
Galactosidase activity (strong blue staining) was detected in the nucleus 
of transfected cells (light purple staining). Note the two sister cells derived 
from a single transfected parental cell. (C) Quantification of reporter-
expressing cells (β-Galactosidase activity) among transfected cells (Alka-
line Phosphatase activity) upon transfection by eukaryotic versions of 
CPP-Cre encoding plasmids. As illustrated for the three indicated pro-
teins, equivalent levels of recombination were reached by the endogenously 
expressed conjugates. (D-E) CV1 cell protein transduction assays: (D) 
CPRG quantification of reporter-expressing cells (β-Galactosidase activ-
ity) upon exposure to 4 μM H3C or H3NC indicates similar transduction 
efficiency of both conjugates, suggesting that the nuclear localization sig-
nal neither improves nor impedes penetratin-mediated Cre delivery. (E) 
CPRG quantification of reporter-expressing cells exposed to 4 μM H3NC 
for either 15 or 60 mn indicates that uptake CPP-Cre conjugate is a fast 
process.




Explant preparation and exposure to protein conjugates. A) Lateral 
view of the brain removed from the head of an E13.5 embryo, to dissect 
out explants from the telencephalon (Tel) or spinal cord (Sc), in the areas 
delineated in red. B) Dorsal view of an adult brain, used to dissect out 
explants from the cerebral cortex (Ctx) or cerebellum (Cb), in the areas 
delineated in red. C-D) View of telencephalic (C) and spinal cord (D) 
explants laying flat on the membrane filter. The asterisks represent the 
center of the 1 μl drop of protein conjugate or vehicle upon deposition at 
the center of the explants, illustrated by the bottom left corner inset (size-
matched 1 μl drop of ink deposited onto a plastic ruler and photographed 
immediately upon surface contact). Note that as the explants pump liquid 
from the culture medium, they create a thin liquid film at the interface 
with the air and surrounding the tissue – the solution rapidly diffuses 
through this film and covers the whole explant surface. E) Same explant 
as represented in Fig. 2D showing the dispersion of the transgene express-
ing cells in the tangential dimension. The asterisk indicates the centre of 
the explant at the time of drop deposition. For the whole figure, the scale 
bar in A represents: A, 1 mm; in B, C, 5.7 mm; in D, 500 μm; in E, 580 
μm.




Lack of transgene expression in Cre-reporter explants from different 
strains upon exposure to vehicle solution. (A-D) Detection of reporter 
gene expression within explants upon Cre transduction in similar condi-
tions to those illustrated in the Fig. 2 drop assay. Vehicle-treated explant 
lack recombinant positive cells (A, B, D: R26R; C: Dbx1-DTA). (E, F) 
Vehicle-soaked beads were applied to an explant from the TGZ strain. 
Neither β-Galactosidase positive nor GFP immunopositive cells could be 
detected (F, higher magnification around the bead implantation site). For 
the whole figure, the scale bar in A represents: A, 400 μm; B, D, 200 μm; 
C, 570 μm; E, 400 μM; F, 700 μm.




CPP-Cre conjugates induced similar recombination levels in drop 
transduction assays. Semi-quantification of the density of reporter-
expressing cells in explants from four transgenic lines upon exposure to a 
1 μl drop of indicated conjugates. 'Activity' is an index of mean recombi-
nation efficiency. Levels were documented by ascribing a qualitative 
appreciation of the amount of reporter induction, and counting the 
number of explants in each category: - or +: indicates none or only a few 
transgene-expressing cells could be detected (as in Fig. 3A and Additional 
file 6A, B); ++: indicates small positive cell clusters – either central or at 
the peripheral border (as in Fig. 2A, C and Additional file 6); +++ or 
++++: describes high density of positive cells within clusters or widespread 
dispersal throughout the explant (e.g. Fig. 2B, 3B–C and Additional file 
6E–H). Explants exposed to vehicle solution did not display induction of 
reporter activity, as illustrated in Additional file 4. The native Cre, tested 
with the RYFP strain, failed to induce significant levels of recombination. 
With the other conjugates (HNC, H3C, H3NC, HCT, H23C, H23NC), 
no significant difference could be detected, as both dense clusters and 
widespread dispersal of positive cells were observed.
Click here for file
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Dose-response of reporter activity in R26R explants upon exposure to 
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of CPP-Cre shows an almost all-or-nothing response with barely detectable 
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bar in A represents: A, 140 μm; B, D, 120 μm; C, E, G, 350 μm; D, 50 
μm; F, 100 μm; H, 80 μm.
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